Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
meperidine
meperidine
- Restricted Narcotic Liquids Formulary
- Restricted Demerol --> Restrictions below.
- Restricted Demerol (PCA) --> Restricted to when alternatives (morphine, DILAUDID, and fentaNYL) can not be used.
- Non-formulary Narcotic - Oral Formulary
Last updated: Dec. 5, 2019
Meperidine is restricted to:
1. Treament of pain in patients when no other opioid can be used.
2. Treatment of drug-induced rigors, shivering, or muscle cramping (max: 100 mg within 24 hrs. as a single dose or divided)
3. One-time dose for pre-procedural sedation (max: 100 mg)
Meperidine PCAs are restricted as above when alternative PCA agents (morphine, DILAUDID, and fentaNYL) can not be used.
IV PCA monitoring and rescue treatments (ADULTS)
Oral (syrup) meperidine is formulary restricted as above.
Meperidine tablets have been discontinued by manufacturers in the United States. As meperdine is recognized as a non-preferred agent for treatment of pain, it is unlikely the tablet formulation will return to the market
meperidine use criteria
Reviewed: January 22, 2013 (Demerol PCA), and April 23, 2013, November 2019